KPV – 10 mg – Research Peptide

KPV 10 mg – Research Peptide

Overview

KPV 10 mg is a synthetic tripeptide composed of lysine, proline, and valine (Lys-Pro-Val), supplied as a lyophilized research material for controlled laboratory and analytical investigation.

KPV corresponds to the C-terminal three-amino-acid sequence of alpha-melanocyte-stimulating hormone (α-MSH) and is also referenced in scientific literature as the α-MSH (11–13) fragment.

KPV has been investigated in experimental systems involving inflammatory signaling pathways, epithelial biology, peptide transport, melanocortin-derived peptide activity, and innate host-defense-associated mechanisms.

Findings involving KPV remain experimental and should be interpreted according to the methodology, experimental model, and limitations of the individual study. They do not establish clinical effectiveness or suitability for human or veterinary use.

Material Information

• Research material: KPV
• Quantity: 10 mg
• Sequence: Lys-Pro-Val
• Peptide length: 3 amino acids
• Related sequence: C-terminal α-MSH (11–13) fragment
• Classification: Synthetic tripeptide
• Form: Lyophilized research material
• Container: Single sealed research vial
• Intended use: Laboratory research use only

Researchers should refer to the product label and applicable batch-specific analytical documentation when evaluating material identity, quantity, purity, and other characteristics.

What Is KPV?

KPV is a three-amino-acid peptide corresponding to the terminal Lys-Pro-Val sequence of α-MSH.

Its compact structure has made KPV useful as an experimental research material for investigating biological activity associated with specific portions of the larger α-MSH peptide without assuming that KPV possesses all characteristics of the complete parent peptide.

Experimental research has examined KPV in connection with cellular signaling, epithelial systems, peptide-transport mechanisms, inflammatory mediators, and host-defense-associated pathways.

Research Characteristics

Experimental research involving KPV may examine:

• NF-κB-associated signaling;
• Cytokine-associated pathways;
• Cellular inflammatory-response mechanisms;
• Epithelial cell biology;
• Peptide transport mechanisms;
• PepT1-associated transport;
• Melanocortin-derived peptide signaling;
• Innate host-defense-associated mechanisms;
• Peptide-microorganism interactions; and
• Comparative activity of α-MSH-derived peptide fragments.

These areas describe subjects of scientific investigation and do not represent established clinical, antimicrobial, anti-inflammatory, or therapeutic effects.

The observation of a molecular pathway, biomarker, or experimental response does not establish safety, effectiveness, or suitability for human or veterinary use.

Laboratory Research Applications

KPV may be investigated in controlled experimental models involving:

• Cellular signaling research: Investigation of NF-κB-associated, cytokine-associated, and related molecular pathways.
• Epithelial biology: Examination of cellular and molecular responses involving epithelial experimental systems.
• Peptide-transport research: Investigation of peptide uptake and transport mechanisms, including PepT1-associated pathways.
• Melanocortin-fragment research: Comparison of KPV with α-MSH and related peptide fragments.
• Host-defense research: Laboratory investigation of peptide interactions involving selected microbial and immune-associated experimental systems.
• Comparative peptide research: Comparison of KPV with other short peptide research materials.
• Analytical research: Characterization of material identity, purity, stability, and related properties.

Experimental design, concentrations, controls, endpoints, and interpretation of findings are determined by the individual laboratory or research protocol.

Handling and Storage

KPV research material should be handled according to applicable institutional procedures, product documentation, and established laboratory practices for peptide research materials.

The lyophilized material should generally be maintained:

• Sealed and protected from moisture;
• Protected from unnecessary exposure to light and heat;
• Under appropriate refrigerated or frozen laboratory storage conditions; and
• In a manner that minimizes unnecessary temperature fluctuations.

Prepared laboratory solutions should be handled according to the applicable experimental protocol and institutional standard operating procedures. Repeated freeze-thaw cycles should be minimized where appropriate.

Appropriate laboratory PPE, aseptic practices, chemical-hygiene procedures, and disposal requirements should be followed.

Technical Summary

No Dosing or Administration Guidance

Tablerock Elite Peptides does not provide or endorse human or veterinary dosing, administration, injection, ingestion, topical application, treatment protocols, reconstitution-for-human-use instructions, or self-administration guidance for KPV 10 mg.

Research Use Only

KPV 10 mg sold by Tablerock Elite Peptides is supplied exclusively for laboratory research use.

It is not supplied as a prescription drug, compounded medication, dietary supplement, cosmetic, antimicrobial product, or other finished pharmaceutical product and is not intended for human or veterinary use.

It must not be used for human or animal injection, ingestion, consumption, topical application, self-administration, diagnosis, treatment, cure, mitigation, prevention, or any other clinical, cosmetic, or therapeutic purpose.

Research Use Only. Not for Human or Veterinary Use.